molnupiravir has been researched along with Leukemia--Lymphocytic--Chronic--B-Cell* in 1 studies
1 other study(ies) available for molnupiravir and Leukemia--Lymphocytic--Chronic--B-Cell
| Article | Year |
|---|---|
Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Ritonavir; SARS-CoV-2 | 2023 |